Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.

Rotavirus infection causes diarrhoeal disease in infants, killing more than half million children each year. Virus-like particles (VLP) seem to be excellent vaccine candidates, since they are cheaper to produce than attenuated viral vaccines and safer, as they do not contain genetic material. The present work focus on a triple layered particle composed by three rotavirus structural proteins: VP2, VP6 and VP7, produced in an insect cell/baculovirus expressing system. Two strategies were evaluated for 2/6/7 VLP production: co-infection with three monocistronic baculovirus vectors or single-infection with a tricistronic multi-gene baculovirus vector; these strategies were followed at different levels: baculovirus DNA replication kinetics, mRNA stability, protein production and VLP formation. This study highlights some of the reasons why the tricistronic baculovirus strategy is more efficient for production of triple layered rotavirus 2/6/7 VLP than monocistronic co-infection, in particular: (i) the tricistronic vector presents higher DNA replication rates than the monocistronic vectors, (ii) the mRNA stability is invariant for all mRNAs corresponding to VP2, VP6 and VP7 and (iii) the tricistronic baculovirus strategy produces an excess of VP7 over VP6 when compared to the VP7/VP6 stoichiometric ratio in the native rotavirus. Although the co-infection strategy leads to protein production akin to the rotavirus VP7/VP6 stoichiometric ratio, the tricistronic vector strategy yields higher amounts of rotavirus-like particles.

[1]  V. Petricevich,et al.  Parameters that determine virus adsorption kinetics: toward the design of better infection strategies for the insect cell - baculovirus expression system. , 2001, Enzyme and microbial technology.

[2]  B. Corsaro,et al.  Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis. , 1998, Biotechnology and bioengineering.

[3]  R Smith,et al.  Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine. , 1999, Vaccine.

[4]  J. Lepault,et al.  Crystallization and Preliminary X-Ray Analysis of Rotavirus Protein VP6 , 1998, Journal of Virology.

[5]  Laura A Palomares,et al.  Strategies for manipulating the relative concentration of recombinant rotavirus structural proteins during simultaneous production by insect cells. , 2002, Biotechnology and bioengineering.

[6]  D. O'reilly,et al.  Autographa californica nucleopolyhedrovirus infection of Spodoptera frugiperda cells: a global analysis of host gene regulation during infection, using a differential display approach. , 2003, The Journal of general virology.

[7]  M. Estes,et al.  Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. , 2003, Vaccine.

[8]  J. Mena,et al.  Titration of non-occluded baculovirus using a cell viability assay. , 2003, BioTechniques.

[9]  M. Estes,et al.  Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells , 1994, Journal of virology.

[10]  H. Brüssow,et al.  Polypeptide composition of rotavirus empty capsids and their possible use as a subunit vaccine , 1990, Journal of virology.

[11]  P. Cruz,et al.  Production of core and virus-like particles with baculovirus infected insect cells. , 2002, Advances in biochemical engineering/biotechnology.

[12]  M. Estes,et al.  Heterotypic Protection and Induction of a Broad Heterotypic Neutralization Response by Rotavirus-Like Particles , 1999, Journal of Virology.

[13]  L. Roberts.  Rotavirus Vaccines' Second Chance , 2004, Science.

[14]  L. Nielsen,et al.  Kinetics of baculovirus replication and release using real-time quantitative polymerase chain reaction. , 2002, Biotechnology and bioengineering.

[15]  M. Estes,et al.  Rotavirus gene structure and function. , 1989, Microbiological reviews.

[16]  M. Carrondo,et al.  Virus‐like particle production at low multiplicities of infection with the baculovirus insect cell system , 2003, Biotechnology and bioengineering.

[17]  J. Bresee,et al.  Rotavirus vaccines: development, current issues and future prospects. , 2002, The Journal of infection.

[18]  J Navaza,et al.  Structural polymorphism of the major capsid protein of rotavirus , 2001, The EMBO journal.

[19]  P. Roy.  Genetically engineered particulate virus-like structures and their use as vaccine delivery systems. , 1996, Intervirology.

[20]  P. Roy,et al.  Assembly of macromolecular complexes in bacterial and baculovirus expression systems. , 1996, Current opinion in structural biology.